1. Home
  2. KLC vs VERA Comparison

KLC vs VERA Comparison

Compare KLC & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLC
  • VERA
  • Stock Information
  • Founded
  • KLC 1969
  • VERA 2016
  • Country
  • KLC United States
  • VERA United States
  • Employees
  • KLC N/A
  • VERA N/A
  • Industry
  • KLC
  • VERA Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLC
  • VERA Health Care
  • Exchange
  • KLC NYSE
  • VERA Nasdaq
  • Market Cap
  • KLC 2.4B
  • VERA 2.4B
  • IPO Year
  • KLC 2024
  • VERA 2021
  • Fundamental
  • Price
  • KLC $19.71
  • VERA $28.58
  • Analyst Decision
  • KLC Buy
  • VERA Buy
  • Analyst Count
  • KLC 8
  • VERA 8
  • Target Price
  • KLC $31.75
  • VERA $66.38
  • AVG Volume (30 Days)
  • KLC 457.0K
  • VERA 985.9K
  • Earning Date
  • KLC 03-20-2025
  • VERA 03-19-2025
  • Dividend Yield
  • KLC N/A
  • VERA N/A
  • EPS Growth
  • KLC N/A
  • VERA N/A
  • EPS
  • KLC 0.07
  • VERA N/A
  • Revenue
  • KLC $2,634,075,000.00
  • VERA N/A
  • Revenue This Year
  • KLC $7.08
  • VERA N/A
  • Revenue Next Year
  • KLC $7.37
  • VERA N/A
  • P/E Ratio
  • KLC $280.29
  • VERA N/A
  • Revenue Growth
  • KLC 6.76
  • VERA N/A
  • 52 Week Low
  • KLC $17.05
  • VERA $25.99
  • 52 Week High
  • KLC $29.89
  • VERA $51.61
  • Technical
  • Relative Strength Index (RSI)
  • KLC N/A
  • VERA 29.57
  • Support Level
  • KLC N/A
  • VERA $25.99
  • Resistance Level
  • KLC N/A
  • VERA $34.79
  • Average True Range (ATR)
  • KLC 0.00
  • VERA 2.15
  • MACD
  • KLC 0.00
  • VERA -0.56
  • Stochastic Oscillator
  • KLC 0.00
  • VERA 20.05

About KLC KINDERCARE LEARNING COMPANIES INC

KinderCare Learning Companies Inc is a private provider of early childhood education and care services (ECE) in the United States. It serves children ranging from 6 weeks to 12 years of age across its market- leading footprint of around 1,480 early childhood education centers with a capacity of more than 194,000 children and contracts for more than 650 before- and after-school sites located in 40 states and the District of Columbia. Its three go-to-market channels are KinderCare Learning Centers, KinderCare Education at Work, and Champions.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: